Review article · 2017 · Open access

Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis

Elizabeth A. Vecchio, Paul James White, Lauren Therese May

Frontiers in Pharmacology, 8, 243 · Published 5 May 2017 · DOI 10.3389/fphar.2017.00243

Open PDFView at the publisherCite this paper

In brief

“Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis” is a 2017 review article by Elizabeth A. Vecchio and 2 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 60 citations as of 21 November 2026, which puts it in the top 6% of works published in 2017 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.

Citations
60
Most cited in
2018 (11)
Field-weighted impact
0.82
References
79
Authors
3

Abstract

Adenosine is a ubiquitous molecule with key regulatory and cytoprotective mechanisms at times of metabolic imbalance in the body. Among a plethora of physiological actions, adenosine has an important role in attenuating ischaemia-reperfusion injury and modulating the ensuing fibrosis and tissue remodelling following myocardial damage. Adenosine exerts these actions through interaction with four adenosine G protein-coupled receptors expressed in the heart. The adenosine A2B receptor (A2BAR) is the most abundant adenosine receptor in cardiac fibroblasts and is largely responsible for the influence of adenosine on cardiac fibrosis. In vitro and in vivo studies demonstrate that acute A2BAR stimulation can decrease fibrosis through the inhibition of fibroblast proliferation and reduction in collagen synthesis. However, in contrast, there is also evidence that chronic A2BAR antagonism reduces tissue fibrosis. This review explores the opposing pro- and anti-fibrotic activity attributed to the activation of cardiac adenosine receptors and investigates the therapeutic potential of targeting adenosine receptors for the treatment of cardiac fibrosis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Vecchio, E. A., White, P. J., & May, L. T. (2017). Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis. Frontiers in Pharmacology, 8, 243. https://doi.org/10.3389/fphar.2017.00243

MLA 9

Vecchio, Elizabeth A., et al. “Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis.” Frontiers in Pharmacology, vol. 8, 2017, p. 243. https://doi.org/10.3389/fphar.2017.00243.

Chicago

Vecchio, Elizabeth A., Paul James White, and Lauren Therese May. 2017. “Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis.” Frontiers in Pharmacology 8: 243. https://doi.org/10.3389/fphar.2017.00243.

Harvard

Vecchio, E. A., White, P. J. and May, L. T. (2017) ‘Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis’, Frontiers in Pharmacology, 8, p. 243. doi:10.3389/fphar.2017.00243.

IEEE

E. A. Vecchio, P. J. White, and L. T. May, “Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis,” Frontiers in Pharmacology, vol. 8, p. 243, 2017, doi: 10.3389/fphar.2017.00243.

BibTeX

@article{vecchio2017targeting,
  title     = {{Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis}},
  author    = {Vecchio, Elizabeth A. and White, Paul James and May, Lauren Therese},
  journal   = {Frontiers in Pharmacology},
  year      = {2017},
  volume    = {8},
  pages     = {243},
  doi       = {10.3389/fphar.2017.00243},
  url       = {https://doi.org/10.3389/fphar.2017.00243}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201744
20181111
201999
202077
202177
202233
202377
202444
202544
202644

Its field-weighted citation impact is 0.82: it has been cited 0.82 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling

  • adenosine receptors
  • myocardial fibrosis
  • adenosine A2B receptor
  • G protein-coupled receptors
  • cardiac fibroblasts
  • ischemia-reperfusion injury
  • fibroblast proliferation
  • collagen synthesis

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Vecchio, E. A., White, P. J., & May, L. T. (2017). Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis. Frontiers in Pharmacology, 8, 243. https://doi.org/10.3389/fphar.2017.00243

How many times has this paper been cited?

60 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Elizabeth A. Vecchio, Paul James White, Lauren Therese May.

What is the DOI of this paper?

10.3389/fphar.2017.00243, permanently at https://doi.org/10.3389/fphar.2017.00243. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.